What this article helps you consider
- Build the solvent history
- Choose targets using evidence
- Understand headspace partitioning
Build the solvent history
Review synthesis, extraction, purification, granulation, coating and other relevant operations. Include solvents introduced through purchased ingredients and recovered materials. A supplier statement should identify the relevant solvents and the basis for its conclusion, rather than refer vaguely to a product as solvent-free.
ICH Q3C(R9) addresses residual solvents in pharmaceutical substances, excipients and products within its scope. It distinguishes solvents to be avoided, solvents to be limited and those with lower toxic potential. Foods and nutraceutical extracts require their own permitted-solvent and residue assessment under the applicable regulations. Pharmaceutical classification does not establish that a solvent is permitted for a food application. R41R21
Choose targets using evidence
Testing every available solvent can create cost without resolving the actual risk. Conversely, a short generic panel can miss a solvent used in the process. Select the analytes using process history, impurity pathways and evidence of removal. Document why an earlier-stage solvent is no longer considered likely to remain where that conclusion is made.
Changes in supplier, drying conditions or solvent recovery can alter the assessment. A control strategy established for one extract or process should not be transferred automatically to another material with a different history.
Understand headspace partitioning
Headspace gas chromatography measures the volatile material entering the gas phase under defined conditions. The signal depends on temperature, equilibration time, vial fill, diluent and the sample matrix. Equal solvent concentrations in two different matrices can produce different responses if their partitioning differs.
The illustration illustrates the relationship between sample and headspace. The conceptual diagram does not imply that all solvent has evaporated or that the sample and vapour have the same concentration. Consistent preparation and demonstrated recovery are central to a useful quantitative procedure.
The measured signal starts with partitioning
Diluent, matrix and preparation influence the fraction entering the gas phase.
Conceptual explanation. No product result, acceptance criterion or universal regulatory sequence is established by this illustration.
Control volatility during preparation
Loss can occur before the vial is sealed through weighing, transfer or mixing. Evaluate the preparation sequence, vial closure and holding time, particularly for volatile targets. Q3C(R9) explicitly identifies solvent volatility as a validation consideration. R41
In a hypothetical recovery experiment, a spiked botanical matrix may initially give low response. Investigate whether the cause is evaporative loss, incomplete equilibration, matrix retention or interference. Increasing the incubation temperature may improve release but can also create degradation or artefacts, so the change requires evaluation rather than automatic acceptance.
Distinguish a screening result from a reportable result
Demonstrate selectivity for relevant solvent pairs and suitable performance around the decision level. Internal standards can help control some variation, but their suitability depends on behaviour relative to the analytes. Standard addition or matrix-matched approaches may be useful when justified by the matrix effect.
Loss on drying measures volatile mass loss under specified conditions. It does not identify individual solvents and can include water or other volatile components. Its use for residual solvent control is limited to justified circumstances under the applicable framework; it cannot distinguish a low concentration of a more hazardous solvent from a larger amount of water. R47
Make the report useful for quality decisions
State the analytes, method, units, reporting limits and material basis. Where exposure calculations are relevant, connect concentration to the maximum daily amount using consistent units. Distinguish a result below the quantitation limit from demonstrated absence. Report deviations or recovery limitations that affect interpretation.
Stabicon can support targeted solvent methods and testing plans that reflect the actual process and matrix, providing results that can be interpreted against the appropriate specification.
References & further reading
Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.
- R41ICH Q3C R9 Impurities Guideline for Residual Solvents
Final minor revision, 2024. Includes consideration of solvent volatility during analytical validation.
- R04ICH Q2 R2 Validation of Analytical Procedures
Final guideline adopted November 2023. Analytical validation framework.
- R47USP General Chapter 731 Loss on Drying
Official publisher preview. Measures volatile mass loss under specified conditions.
- R21FSSAI Health Supplements and Nutraceuticals Standards
Official regulations portal. Verify current amendments, permitted ingredients, levels and category-specific requirements.
From insight to a defined programme
Bring your next technical question.
Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.
Discuss this topic with Stabicon






